PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

R.R. Wildeboer, R.J.G. van Sloun, P. Huang, H. Wijkstra, M. Mischi (Corresponding author)

Research output: Contribution to journalConference articleAcademicpeer-review

Abstract

Introduction & Objectives: A non-targeted 12-core systematic biopsy (SBx) procedure guided by transrectal ultrasound (TRUS) is currently guideline-recommended for prostate cancer (PCa) diagnosis. Despite the risk of complications, underdiagnosis, and overtreatment associated with SBx, until now image-based targeted biopsy has not proven sufficiently accurate to replace SBx. Three-dimensional (3D) dynamic contrastenhanced ultrasound (DCE-US) was recently introduced for prostate imaging, permitting to image the entire gland with a single bolus injection. Quantitative two-dimensional DCE-US has already shown promising for PCa localization. Here, we present a new method for PCa localization by multiparametric analysis of 3D DCE-US.
Original languageEnglish
Pages (from-to)e1870-e1871
Number of pages2
JournalEuropean Urology Supplements
Volume18
Issue number1
DOIs
Publication statusPublished - 2019
Event34th Annual EAU Congress European Association of Urology (EAU19) - Fira Gran Via, Barcelona, Spain
Duration: 15 Mar 201919 Mar 2019
https://eaucongress.uroweb.org/

Fingerprint

Prostatic Neoplasms
Biopsy
Prostate
Guidelines
Injections
Medical Overuse

Bibliographical note

Abstracts EAU19 – 34th Annual EAU Congress

Cite this

@article{9779446869dc4e189b09c151de88df86,
title = "PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy",
abstract = "Introduction & Objectives: A non-targeted 12-core systematic biopsy (SBx) procedure guided by transrectal ultrasound (TRUS) is currently guideline-recommended for prostate cancer (PCa) diagnosis. Despite the risk of complications, underdiagnosis, and overtreatment associated with SBx, until now image-based targeted biopsy has not proven sufficiently accurate to replace SBx. Three-dimensional (3D) dynamic contrastenhanced ultrasound (DCE-US) was recently introduced for prostate imaging, permitting to image the entire gland with a single bolus injection. Quantitative two-dimensional DCE-US has already shown promising for PCa localization. Here, we present a new method for PCa localization by multiparametric analysis of 3D DCE-US.",
author = "R.R. Wildeboer and {van Sloun}, R.J.G. and P. Huang and H. Wijkstra and M. Mischi",
note = "Abstracts EAU19 – 34th Annual EAU Congress",
year = "2019",
doi = "10.1016/S1569-9056(19)31354-5",
language = "English",
volume = "18",
pages = "e1870--e1871",
journal = "European Urology Supplements",
issn = "1569-9056",
publisher = "Elsevier",
number = "1",

}

PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy. / Wildeboer, R.R.; van Sloun, R.J.G.; Huang, P.; Wijkstra, H.; Mischi, M. (Corresponding author).

In: European Urology Supplements, Vol. 18, No. 1, 2019, p. e1870-e1871.

Research output: Contribution to journalConference articleAcademicpeer-review

TY - JOUR

T1 - PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

AU - Wildeboer, R.R.

AU - van Sloun, R.J.G.

AU - Huang, P.

AU - Wijkstra, H.

AU - Mischi, M.

N1 - Abstracts EAU19 – 34th Annual EAU Congress

PY - 2019

Y1 - 2019

N2 - Introduction & Objectives: A non-targeted 12-core systematic biopsy (SBx) procedure guided by transrectal ultrasound (TRUS) is currently guideline-recommended for prostate cancer (PCa) diagnosis. Despite the risk of complications, underdiagnosis, and overtreatment associated with SBx, until now image-based targeted biopsy has not proven sufficiently accurate to replace SBx. Three-dimensional (3D) dynamic contrastenhanced ultrasound (DCE-US) was recently introduced for prostate imaging, permitting to image the entire gland with a single bolus injection. Quantitative two-dimensional DCE-US has already shown promising for PCa localization. Here, we present a new method for PCa localization by multiparametric analysis of 3D DCE-US.

AB - Introduction & Objectives: A non-targeted 12-core systematic biopsy (SBx) procedure guided by transrectal ultrasound (TRUS) is currently guideline-recommended for prostate cancer (PCa) diagnosis. Despite the risk of complications, underdiagnosis, and overtreatment associated with SBx, until now image-based targeted biopsy has not proven sufficiently accurate to replace SBx. Three-dimensional (3D) dynamic contrastenhanced ultrasound (DCE-US) was recently introduced for prostate imaging, permitting to image the entire gland with a single bolus injection. Quantitative two-dimensional DCE-US has already shown promising for PCa localization. Here, we present a new method for PCa localization by multiparametric analysis of 3D DCE-US.

U2 - 10.1016/S1569-9056(19)31354-5

DO - 10.1016/S1569-9056(19)31354-5

M3 - Conference article

VL - 18

SP - e1870-e1871

JO - European Urology Supplements

JF - European Urology Supplements

SN - 1569-9056

IS - 1

ER -